Imidazopyrazine syk inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/444 (2006.01) A61K 31/4985 (2006.01) A61K 31/501 (2006.01) A61K 31/5377 (2006.01) A61K 31/538 (2006.01) C07D 401/12 (2006.01) C07D 471/04 (2006.01) C07D 519/00 (2006.01) G01N 33/50 (2006.01)

Patent

CA 2745871

Certain imidazopyrazines and pharmaceutical compositions thereof are provided herein. Methods of treating pa-tients suffering from certain diseases and disorders responsive to the inhibition of Syk activity, which comprises administering to such patients an amount of at least one chemical entity effective to reduce signs or symptoms of the disease or disorder are provid-ed. Also provided are methods for determining the presence or absence of Syk kinase in a sample.

L'invention porte sur certaines imidazopyrazines et sur leurs compositions pharmaceutiques. L'invention porte sur des méthodes de traitement de patients souffrant de certaines maladies et de certains troubles sensibles à l'inhibition de l'activité Syk consistant à administrer à de tels patients une quantité d'au moins une entité chimique efficace pour réduire les signes ou symptômes de la maladie ou du trouble. L'invention porte également sur des méthodes de détermination de la présence ou de l'absence de la kynase Syk dans un échantillon.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Imidazopyrazine syk inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Imidazopyrazine syk inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazopyrazine syk inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1828987

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.